Osaka, Japan-based Santen Pharmaceutical Co., Ltd. Deploys its Sales Analysis System On the MicroStrategy Business Intelligence Platform
MicroStrategy® Incorporated (NASDAQ: MSTR), a leading worldwide provider of business intelligence software, and MicroStrategy distributor JMA Systems today announced that Santen Pharmaceutical Co., Ltd. has rebuilt its sales analysis system on MicroStrategy 7�. Santen Pharmaceutical Co. is dedica
McLean, Va., (April 15, 2002) –
MicroStrategy® Incorporated (NASDAQ: MSTR), a leading worldwide provider of business intelligence software, and MicroStrategy distributor JMA Systems today announced that Santen Pharmaceutical Co., Ltd. has rebuilt its sales analysis system on MicroStrategy 7(TM). Santen Pharmaceutical Co. is dedicated to innovations in eye and healthcare, and devotes its managerial resources to developing ophthalmic and anti-rheumatic pharmaceuticals.
After evaluating numerous business intelligence vendors, Santen Pharmaceutical Co., Ltd. chose MicroStrategy for its ability to meet Santen’s current business intelligence needs and provide Web-based functionality across the enterprise. With MicroStrategy 7, Santen Pharmaceutical Co. has an integrated business intelligence platform that can keep up with constantly evolving user requirements. The MicroStrategy system will allow Santen’s sales representatives throughout Japan to focus on their sales activity using only a Web browser.
“MicroStrategy’s software platform is highly scalable, offers superior performance and allows our end users to obtain critical business insight with ease,” said Santen Pharmaceutical’s General Manager for the Corporate Services and IS Solution Group. “Santen Pharmaceutical aims to drive sales activity with its MicroStrategy Business Intelligence Platform.”
About Santen Pharmaceutical Co., Ltd.
Since its founding more than 110 years ago, Santen has been dedicated to innovations in eye and healthcare. As an integrated pharmaceutical company, Santen is involved in research and development, production and sale of prescription and over-the-counter (OTC) pharmaceuticals. Santen concentrates its managerial resources in ophthalmic and anti-rheumatic pharmaceuticals and is committed to conducting basic studies of diseases and their pathologies and developing new products that meet the needs of medical professionals and their patients. Sales to medical institutions and pharmaceutical retailers are promoted through the use of the Company’s extended information network and experience in its specialties.
About MicroStrategy Incorporated
Leadership in a Critical Market: Founded in 1989, MicroStrategy is a worldwide leader in the critical business intelligence software market. Large and small companies alike are harnessing MicroStrategy’s business intelligence software to gain vital insights from their data to help them proactively enhance cost-efficiency, productivity and customer relations and optimize revenue-generating strategies. MicroStrategy’s business intelligence platform offers exceptional capabilities that provide organizations — in virtually all facets of their operations — with user-friendly solutions to their data query, reporting, and advanced analytical needs, and distributes valuable insight on this data to users via Web, wireless, and voice. PC Magazine recently selected MicroStrategy 7(TM) as the 2001 “Editors’ Choice” for business intelligence software.
Built for the Internet: MicroStrategy 7 is the Scalable Business Intelligence Platform Built for the Internet(TM). Its pure-Web architecture provides Web reporting, security, performance and standards that are critical for Web deployment. Within intranets, MicroStrategy’s products provide employees with information to enable them to make better, more cost-effective business decisions. In extranets, enterprises can use MicroStrategy 7 to build stronger relationships by linking customers and suppliers via the Internet.
Diverse Customer Base: MicroStrategy’s customer base cuts across industry and sector lines, with approximately 1,500 enterprise-class customers, including Lowe’s Home Improvement Warehouse, AT&T Wireless Group, Wachovia and GlaxoSmithKline. MicroStrategy also has relationships with over 400 systems integrators and application development and platform partners, including IBM, PeopleSoft, Compaq, Informatica and JD Edwards.
MicroStrategy is listed on Nasdaq under the symbol MSTR. For more information on the company, or to purchase or demo MicroStrategy’s software, please visit MicroStrategy’s Web site at http://www.microstrategy.com.
This press release may include statements that may constitute “forward- looking statements,” including its estimates of future business prospects or financial results and statements containing the words “believe,” “estimate,” “project,” “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results of MicroStrategy Incorporated and its subsidiaries (collectively, the “Company”) to differ materially from the forward-looking statements. Factors that could contribute to such differences include: the possibility that the conditions to the securities class action and shareholder derivative settlement agreements will not be satisfied; the Company’s ability to secure financing for its current operations and long-term plans on acceptable terms; the ability of the Company to implement and achieve widespread customer acceptance of its MicroStrategy 7 software on a timely basis; the Company’s ability to recognize deferred revenue through delivery of products or satisfactory performance of services; the timely release of the MicroStrategy 7i platform; continued acceptance of the Company’s products in the marketplace; the timing of significant orders; delays in the Company’s ability to develop or ship new products; market acceptance of new products; competitive factors; general economic conditions; currency fluctuations and other risks detailed in the Company’s registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
MicroStrategy, MicroStrategy Business Intelligence Platform, MicroStrategy 7, Scalable Business Intelligence Platform Built for the Internet, MicroStrategy Web are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.
Alka Nayyar
MicroStrategy Incorporated
(703) 847-4897
anayyar@microstrategy.com
Source: MicroStrategy